Zealand Pharma A/S
CSE:ZEAL

Watchlist Manager
Zealand Pharma A/S Logo
Zealand Pharma A/S
CSE:ZEAL
Watchlist
Price: 775.5 DKK 0.78% Market Closed
Market Cap: 54.8B DKK
Have any thoughts about
Zealand Pharma A/S?
Write Note

Wall Street
Price Targets

ZEAL Price Targets Summary
Zealand Pharma A/S

Wall Street analysts forecast ZEAL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZEAL is 1 030.63 DKK with a low forecast of 823.15 DKK and a high forecast of 1 155 DKK.

Lowest
Price Target
823.15 DKK
6% Upside
Average
Price Target
1 030.63 DKK
33% Upside
Highest
Price Target
1 155 DKK
49% Upside
Zealand Pharma A/S Competitors:
Price Targets
MRUS
Merus NV
102% Upside
ZYME
Zymeworks Inc
41% Upside
ITOS
Iteos Therapeutics Inc
317% Upside
MYGN
Myriad Genetics Inc
59% Upside
GILD
Gilead Sciences Inc
10% Upside
DYAI
Dyadic International Inc
456% Upside
INO
Inovio Pharmaceuticals Inc
163% Upside
VCYT
Veracyte Inc
3% Upside

Revenue
Forecast

Revenue Estimate
Zealand Pharma A/S

For the last 8 years the compound annual growth rate for Zealand Pharma A/S's revenue is 8%. The projected CAGR for the next 3 years is 81%.

8%
Past Growth
81%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Zealand Pharma A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Zealand Pharma A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ZEAL's stock price target?
Price Target
1 030.63 DKK

According to Wall Street analysts, the average 1-year price target for ZEAL is 1 030.63 DKK with a low forecast of 823.15 DKK and a high forecast of 1 155 DKK.

What is Zealand Pharma A/S's Revenue forecast?
Projected CAGR
81%

For the last 8 years the compound annual growth rate for Zealand Pharma A/S's revenue is 8%. The projected CAGR for the next 3 years is 81%.

Back to Top